167 related articles for article (PubMed ID: 12439743)
21. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter.
Kamano H; Klempnauer KH
Oncogene; 1997 Mar; 14(10):1223-9. PubMed ID: 9121772
[TBL] [Abstract][Full Text] [Related]
22. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus.
Zini N; Trimarchi C; Claudio PP; Stiegler P; Marinelli F; Maltarello MC; La Sala D; De Falco G; Russo G; Ammirati G; Maraldi NM; Giordano A; Cinti C
J Cell Physiol; 2001 Oct; 189(1):34-44. PubMed ID: 11573202
[TBL] [Abstract][Full Text] [Related]
23. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis.
Ruiz S; Santos M; Segrelles C; Leis H; Jorcano JL; Berns A; Paramio JM; Vooijs M
Development; 2004 Jun; 131(11):2737-48. PubMed ID: 15148303
[TBL] [Abstract][Full Text] [Related]
24. G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein.
Gonzales AJ; Fry DW
Exp Cell Res; 2005 Feb; 303(1):56-67. PubMed ID: 15572027
[TBL] [Abstract][Full Text] [Related]
25. Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity.
Ziebold U; Klempnauer KH
Oncogene; 1997 Aug; 15(9):1011-9. PubMed ID: 9285555
[TBL] [Abstract][Full Text] [Related]
26. The retinoblastoma protein is essential for cyclin A repression in quiescent cells.
Philips A; Huet X; Plet A; Le Cam L; Vié A; Blanchard JM
Oncogene; 1998 Mar; 16(11):1373-81. PubMed ID: 9525736
[TBL] [Abstract][Full Text] [Related]
27. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.
Pilkinton M; Sandoval R; Colamonici OR
Oncogene; 2007 Nov; 26(54):7535-43. PubMed ID: 17563750
[TBL] [Abstract][Full Text] [Related]
28. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
[TBL] [Abstract][Full Text] [Related]
29. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
30. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
[TBL] [Abstract][Full Text] [Related]
31. p107 and p130: versatile proteins with interesting pockets.
Classon M; Dyson N
Exp Cell Res; 2001 Mar; 264(1):135-47. PubMed ID: 11237530
[TBL] [Abstract][Full Text] [Related]
32. The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity.
Sala A; De Luca A; Giordano A; Peschle C
J Biol Chem; 1996 Nov; 271(46):28738-40. PubMed ID: 8910512
[TBL] [Abstract][Full Text] [Related]
33. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation.
Kong HJ; Yu HJ; Hong S; Park MJ; Choi YH; An WG; Lee JW; Cheong J
Mol Cancer Res; 2003 Nov; 1(13):948-58. PubMed ID: 14638867
[TBL] [Abstract][Full Text] [Related]
34. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
Lam EW; Morris JD; Davies R; Crook T; Watson RJ; Vousden KH
EMBO J; 1994 Feb; 13(4):871-8. PubMed ID: 8112300
[TBL] [Abstract][Full Text] [Related]
35. Transactivation mediated by B-Myb is dependent on TAF(II)250.
Bartusel T; Klempnauer KH
Oncogene; 2003 May; 22(19):2932-41. PubMed ID: 12771944
[TBL] [Abstract][Full Text] [Related]
36. Dissecting functions of the retinoblastoma tumor suppressor and the related pocket proteins by integrating genetic, cell biology, and electrophoretic techniques.
Hansen K; Lukas J; Holm K; Kjerulff AA; Bartek J
Electrophoresis; 1999 Feb; 20(2):372-81. PubMed ID: 10197445
[TBL] [Abstract][Full Text] [Related]
37. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
[TBL] [Abstract][Full Text] [Related]
38. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107.
Chibazakura T; McGrew SG; Cooper JA; Yoshikawa H; Roberts JM
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4465-70. PubMed ID: 15070741
[TBL] [Abstract][Full Text] [Related]
39. B-Myb protein in cellular proliferation, transcription control, and cancer: latest developments.
Sala A; Watson R
J Cell Physiol; 1999 Jun; 179(3):245-50. PubMed ID: 10228942
[TBL] [Abstract][Full Text] [Related]
40. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells.
Sala A; Casella I; Bellon T; Calabretta B; Watson RJ; Peschle C
J Biol Chem; 1996 Apr; 271(16):9363-7. PubMed ID: 8621601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
